Evidence map›Paper›PMID 36592307›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Base Editing of Human Hematopoietic Stem Cells.

Jing Zeng, Gabriele Casirati, My Anh Nguyen, Pietro Genovese, Daniel E Bauer

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jing ZengDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Gabriele CasiratiDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
My Anh NguyenDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Pietro GenoveseDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Daniel E BauerDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. Daniel.Bauer@childrens.harvard.edu.
Harvard Stem Cell Institute · USBoston Children's Hospital · USDana-Farber Cancer Institute · US

Funding

VIROSOME/PROTEOLIPOSOME MEDIATED GENE TRANSFERP01HL053749 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GOTTSCHALK, STEPHEN · 1994 to 2022
$43.6M
Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patientsOT2HL154984 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI BAUER, DANIEL EVAN · 2020 to 2021
$2.6M
Development, Optimization and Preclinical Modeling of Hematopoietic Stem Cell Gene Editing for the Treatment of RAG1 ImmunodeficiencyR01AI155796 · NIAID · DANA-FARBER CANCER INST · PI GENOVESE, PIETRO · 2021 to 2025
$2.2M
NHLBI NIH HHS OT2 HL154984NHLBI NIH HHS P01 HL053749NIAID NIH HHS R01 AI155796
6 · The paper itself

Abstract

Base editing by nucleotide deaminases linked to programmable DNA-binding proteins represents a promising approach to remedy blood disorders. Here we describe the ex vivo base editing of human CD34+ hematopoietic stem and progenitor cells (HSPCs) by electroporation of base editor mRNA or protein.

Indexed as

Gene EditingHematopoietic Stem Cell TransplantationAntigens, CD34Hematopoietic Stem CellsHumansAntigens, CD34Base editingCD34+ hematopoietic stem and progenitor cellsElectroporation

Identifiers

PMID36592307
PMCPMC11452822
OpenAlexW4313482030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.